Notable Analyst Rating Changes 2/19: (COH) (VLO) (MWW) Upgraded; (I) (PCYC) (HUN) Downgraded Feb 19, 2015 10:47AM
Pre-Open Stock Movers 02/19: (BJRI) (PCLN) (BBW) Higher; (OCRX) (NLST) (CSLT) Lower (more...) Feb 19, 2015 09:21AM
UPDATE: Roth Capital Cuts Pharmacyclics (PCYC) to Neutral; Sees FY15 Guidance, Market Expectations Priced into Shares Feb 19, 2015 08:59AM
Streetinsider.com's Hot Lunchtime Reads 1/29: (AAPL) (PCYC) (AERI) (AMZN) Jan 29, 2015 12:14PM
Roth Capital Bumps PT on Pharmacyclics (PCYC) to $189 Following Expanded IMBRUVICA Indication Jan 29, 2015 11:50AM


Jan 14, 2015 07:52AM Roth Remains Positive on Pharmacyclics (PCYC) Following Imbruvica Update; Maintains 'Buy' Rating
Jan 5, 2015 11:57AM Roth Comments on Pharmacyclics (PCYC) Following Publication on New Imbruvica Data
Dec 10, 2014 10:58AM Roth Boosts PT on TG Therapeutics (TGTX) to $33 on Strong ASH Showing, Buyout Prospects
Dec 9, 2014 12:39PM Pharmacyclics (PCYC) Impresses at ASH; KOLs Excited About Prospects for Imbruvica - Roth Capital
Oct 17, 2014 09:24AM Roth Boosts PT on Pharmacyclics (PCYC) to $188; Imbruvica Continues to Gain Traction
Oct 13, 2014 11:52AM New Pharmacyclics (PCYC) Collaboration Further Validates Imbruvica; Roth Boosts PT to $185
Sep 16, 2014 10:45AM Roth Sees 'Significant' and 'Impressive' Cost Efficiencies in TG Therapeutics' (TGTX) CLL Combo Phase 3
Jul 28, 2014 02:07PM Roth Capital Comments on Pharmacyclics (PCYC) Following Expanded IMBRUVICA Coverage; Affirms 'Buy' Rating
Jul 25, 2014 08:58AM Roth Positive on Pharmacyclics (PCYC) Following CHMP Recommendation of Imbruvica
Jun 9, 2014 10:20AM Roth Keeps Pharmacyclics (PCYC) at 'Buy'; Imbruvica sNDA Selected for Priority Review by FDA
Jun 4, 2014 08:08AM Pharmacyclics (PCYC) KOL Event at ASCO Impresses Physicians; Roth Keeps at 'Buy'
Jun 2, 2014 10:06AM Roth Keeps Pharmacyclics (PCYC) at Buy; Still Positive on Imbruvica Following Phase III RESONTAE
May 5, 2014 11:37AM Pharmacyclics (PCYC) Story Unchanged Following Q1 Report; Roth Reiterates at 'Buy'
Apr 8, 2014 09:32AM Pharmacyclics' (PCYC) IMBRUVICA Should Get Full Approval Before End of 2014; Roth Keeps at 'Buy'
Feb 24, 2014 02:15PM Pharmacyclics' (PCYC) IMBRUVICA Drives Strong Q4 Results; Roth Boosts PT to $183
Feb 24, 2014 02:10PM Pharmacyclics (PCYC) PT Raised to $183 at Roth Capital
Feb 13, 2014 07:52AM Roth Capital Boosts PT on Pharmacyclics (PCYC) to $166; Strong IMBRUVICA Sales Ramp Expected
Oct 30, 2013 03:29PM Pharmacyclics (PCYC) Target Raised to $144 at Roth Capital
Aug 20, 2012 10:57AM Notable Analyst Rating Changes 08/20: (ROST) (PB) (STO) Upgraded; (STEM) (STX) (PCYC) Downgraded
Aug 20, 2012 06:51AM Roth Capital Downgrades Pharmacyclics (PCYC) to Neutral
Mar 12, 2010 07:22AM Roth Capital Initiates Coverage on Pharmacyclics (PCYC) with a Buy